AzTrials
AzTrials

PulpitisNCT07379515

Effects of Topical Anesthesia Approaches on Dental Pain During and After Restorative Management of Dental Caries

A study testing Photobiomodulation (PBM)-induced analgesia device using multi-wavelength LED and Medicated analgesia in people with Pulpitis and Pain Management, run by Dubai Health.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

The purpose of the Research Study and Overview of Participation: This study will compare different approaches used to prevent pain when giving local anesthesia to numb the teeth while managing dental cavities and decay. Read more about this study

Who is it for?
Ages 18 to 59 years
Conditions the study is for
Pulpitis, Pain Management
What is being tested?
Photobiomodulation (PBM)-induced analgesia device using multi-wavelength LED and Medicated analgesia
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
204 participants
Where
No sites listed yet
Study dates
15 Apr 2026to 31 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 59 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Healthy participants: American Society of Anesthesiology Class I or II
  • Adults aged 18-59 years
  • No history of allergy to local anesthesia or excipients included in the vial
  • Participant requiring caries management for a maxillary premolar tooth (ICDAS I-V), with reversible pulpitis.

Who cannot join

  • American Society of Anesthesiology Class III or higher
  • Participants with systemic conditions affecting pain perception
  • Participants on chronic pain medication
  • Pregnant or breastfeeding women
  • History of allergy to topical/local anesthesia
  • Taking any analgesic 48 hours before testing, such as an NSAID, opioids, or
Show all 9Show fewer
  • acetaminophen
  • Recent oral trauma
  • Deep carious lesion with irreversible pulpitis or pulpal necrosis

About this study

Official title: Effects of Topical Anesthesia Approaches on Dental Pain During and After Restorative Management of Dental Caries - Randomized Clinical Trial

The purpose of the Research Study and Overview of Participation: This study will compare different approaches used to prevent pain when giving local anesthesia to numb the teeth while managing dental cavities and decay. Specifically, it seeks to determine which approach will reduce the pain and discomfort during or after the procedure. This will help dentists to choose the best approach to reduce patient's pain and discomfort and improve the overall experience of dental treatment.

Participants in the study would likely undergo the following:

Read more
  1. Screening and Consent: Participants would be assessed for eligibility (e.g., age, health status, and presence of dental caries requiring treatment) and would provide informed consent.
  2. Intervention: Participants would be randomly assigned to different groups based on the type or method of topical anesthesia being tested.
  3. Treatment Procedure: Dental caries management would be performed under local anesthesia, with the designated topical anesthetic applied beforehand.
  4. Pain Assessment: Participants would rate their pain levels during and after the procedure using validated pain measurement scales (e.g., visual analog scale).
  5. Follow-Up: Participants might be monitored for a short duration post-treatment to assess any residual pain or side effects.

This design ensures that the study collects reliable data on the effectiveness of the different topical anesthetic approaches while prioritizing patient safety and comfort.

Being tested
Photobiomodulation (PBM)-induced analgesia device using multi-wavelength LED, Medicated analgesia, Placebo
Medical subject headings
Pulpitis, Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Photobiomodulation (PBM)-induced analgesia device using multi-wavelength LEDDevice

    Photobiomodulation (PBM)-induced analgesia device using multi-wavelength LED

  • Medicated analgesiaOther

    Topical anesthesia (Benzocaine 20%)

  • PlaceboOther

    Placebo with no intervention.

Study groups in NCT07379515
Study groupRoleWhat they receive
Non-medicated anelgesiaExperimentalNot described
Receives: Device: Photobiomodulation (PBM)-induced analgesia device using multi-wavelength LED
PlaceboPlacebo comparatorPlacebo
Receives: Other: Placebo
Medicated anelgesiaActive comparatorNot described
Receives: Other: Medicated analgesia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain score after local anesthesia administration, dental procedure, and 48 hours postoperatively.

    Pain score based on Visual Analog Scale (1-10) with highest score indicates the most severe pain.

    Measured: Within 5 minutes after local anesthesia administration, during dental procedure, directly after finishing the procedure, and 48 hours postoperatively.

Secondary outcomes (5)
  1. Pain score with prick pain test (PPT)

    Pain score will be reported as "pain" or "no pain".

    Measured: One minute after topical anesthesia.

  2. Pain score with pulpal stimulation using electric pulp tester (EPT)

    Digital reading from 1 to 64 with the highest score indicates no pain response on electric stimulation.

    Measured: After 2 minutes of topical anesthesia.

  3. Amount of local anesthesia to be given

    Counting the number of used local anesthetic carpules.

    Measured: At the end of dental procedure.

  4. Need for additional analgesics

    Count the number and dose of oral analgesics taken by the patient.

    Measured: Within 48 hours postoperatively.

  5. Reporting of any adverse effects, such as mucosal irritation, allergic reactions, and delayed pain relief.

    Reported by the patient.

    Measured: Within 48 hours postoperatively.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2026
  2. Study start15 Apr 2026 (estimated)
  3. Primary completion31 Jul 2026 (estimated)
  4. Study completion31 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
204 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07379515
Sponsor's protocol ID
MBRU IRB-2024-695
Status last verified
Apr 2026
First submitted
8 Dec 2025
Last updated
13 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Photobiomodulation (PBM)-induced analgesia device using multi-wavelength LED and Medicated analgesia in people with Pulpitis and Pain Management, run by Dubai Health.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 13 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain score after local anesthesia administration, dental procedure, and 48 hours postoperatively. (time frame: Within 5 minutes after local anesthesia administration, during dental procedure, directly after finishing the procedure, and 48 hours postoperatively.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in